549 related articles for article (PubMed ID: 24592925)
1. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
[TBL] [Abstract][Full Text] [Related]
2. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.
Taylor SL; Rogers GB; Chen AC; Burr LD; McGuckin MA; Serisier DJ
Ann Am Thorac Soc; 2015 May; 12(5):701-7. PubMed ID: 25679336
[TBL] [Abstract][Full Text] [Related]
4. Predominant pathogen competition and core microbiota divergence in chronic airway infection.
Rogers GB; van der Gast CJ; Serisier DJ
ISME J; 2015 Jan; 9(1):217-25. PubMed ID: 25036925
[TBL] [Abstract][Full Text] [Related]
5. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ
Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
[TBL] [Abstract][Full Text] [Related]
6. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A
Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914
[TBL] [Abstract][Full Text] [Related]
7. Microbiologic follow-up study in adult bronchiectasis.
King PT; Holdsworth SR; Freezer NJ; Villanueva E; Holmes PW
Respir Med; 2007 Aug; 101(8):1633-8. PubMed ID: 17467966
[TBL] [Abstract][Full Text] [Related]
8. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
[TBL] [Abstract][Full Text] [Related]
9. Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients.
Dimakou K; Triantafillidou C; Toumbis M; Tsikritsaki K; Malagari K; Bakakos P
Respir Med; 2016 Jul; 116():1-7. PubMed ID: 27296814
[TBL] [Abstract][Full Text] [Related]
10. Sputum bacteriology in steady-state bronchiectasis in Guangzhou, China.
Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Li HM; Lin ZM; Zheng JP; Chen RC; Zhong NS
Int J Tuberc Lung Dis; 2015 May; 19(5):610-9. PubMed ID: 25868032
[TBL] [Abstract][Full Text] [Related]
11. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.
Roche N; Kouassi B; Rabbat A; Mounedji A; Lorut C; Huchon G
Respiration; 2007; 74(1):19-25. PubMed ID: 16675894
[TBL] [Abstract][Full Text] [Related]
12.
Taylor SL; Woodman RJ; Chen AC; Burr LD; Gordon DL; McGuckin MA; Wesselingh S; Rogers GB
Thorax; 2017 Apr; 72(4):304-310. PubMed ID: 27503233
[TBL] [Abstract][Full Text] [Related]
13. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282
[No Abstract] [Full Text] [Related]
14. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
Syed SA; Whelan FJ; Waddell B; Rabin HR; Parkins MD; Surette MG
Ann Am Thorac Soc; 2016 Dec; 13(12):2132-2142. PubMed ID: 27925791
[TBL] [Abstract][Full Text] [Related]
15. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.
Byun MK; Chang J; Kim HJ; Jeong SH
PLoS One; 2017; 12(8):e0183553. PubMed ID: 28829833
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
[TBL] [Abstract][Full Text] [Related]
17. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.
Wilson CB; Jones PW; O'Leary CJ; Hansell DM; Cole PJ; Wilson R
Eur Respir J; 1997 Aug; 10(8):1754-60. PubMed ID: 9272915
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and chronic colonization of
Tufvesson E; Markstad H; Bozovic G; Ekberg M; Bjermer L
Int J Chron Obstruct Pulmon Dis; 2017; 12():3211-3219. PubMed ID: 29138549
[TBL] [Abstract][Full Text] [Related]
19. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.
Venning V; Bartlett J; Jayaram L
Respirology; 2017 Jul; 22(5):922-927. PubMed ID: 28236369
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.
Cox MJ; Turek EM; Hennessy C; Mirza GK; James PL; Coleman M; Jones A; Wilson R; Bilton D; Cookson WO; Moffatt MF; Loebinger MR
PLoS One; 2017; 12(2):e0170622. PubMed ID: 28170403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
